Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Cash & Current Investments (2016 - 2025)

Dentsply Sirona's Cash & Current Investments history spans 17 years, with the latest figure at $326.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 19.85% year-over-year to $326.0 million, compared with a TTM value of $326.0 million through Dec 2025, up 19.85%, and an annual FY2025 reading of $326.0 million, up 19.85% over the prior year.
  • Cash & Current Investments for Q4 2025 was $326.0 million at Dentsply Sirona, down from $363.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $418.0 million in Q3 2022, with the low at $272.0 million in Q4 2024.
  • Average Cash & Current Investments over 5 years is $332.6 million, with a median of $329.0 million recorded in 2021.
  • Year-over-year, Cash & Current Investments tumbled 77.91% in 2021 and then surged 48.75% in 2022.
  • Tracing XRAY's Cash & Current Investments over 5 years: stood at $361.0 million in 2021, then grew by 1.11% to $365.0 million in 2022, then dropped by 8.49% to $334.0 million in 2023, then dropped by 18.56% to $272.0 million in 2024, then increased by 19.85% to $326.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Cash & Current Investments are $326.0 million (Q4 2025), $363.0 million (Q3 2025), and $359.0 million (Q2 2025).